Home Overview Press Room Blog Publications For Students about us
Search

About the States' Policies & Human Biotechnology


Individual states are filling the regulatory void created by the federal government’s failure to provide comprehensive legislation governing human biotechnologies. This is creating an often inconsistent policy patchwork.

California

State action is evident in a number of areas, including embryonic stem cell, cloning, egg retrieval, and assisted reproduction. More than a dozen states have laws banning reproductive cloning, about half of which also prohibit cloning for stem cell research. Dozens of similar bills are introduced in other states each year.

In response to President Bush’s restrictions on the federal funding of human embryonic stem cell research, several states initiated their own funded research programs. California led the way in 2004 with Proposition 71, which set aside $3 billion of public funds for stem cell research over ten years.



What’s behind those billion-dollar biotech deals? Often, a whole lot of hypeby Damian GardeSTATNovember 28th, 2016New deals paid out with “biobucks” which only pay out when an experimental drug hits various milestones along the path to commercialization.
Abortion-By-Mail Study Outrages Opponentsby Phil GalewitzKQED California HealthlineNovember 16th, 2016Gynuity Health Projects pilots a study in Hawaii, New York, Oregon, and Washington that uses telemedicine as an alternative for declining access.
Where Traditional DNA Testing Fails, Algorithms Take Overby Lauren KirchnerProPublicaNovember 4th, 2016Various "probabilistic genotyping" programs undermine due process as defense attorneys, judges, and jurors can't access their proprietary inner workings.
The controversial DNA search that helped nab the 'Grim Sleeper' is winning over skepticsby Marisa GerberLos Angeles TimesOctober 25th, 2016Use of familial DNA to solve crimes is growing in popularity, raising concerns of 4th Amendment unreasonable search and seizure violations.
President signs Senate bill that protects eugenics victimsby Richard CraverWinston-Salem JournalOctober 7th, 2016State restitution payments will not decrease or eliminate federal benefits for people who were forcibly sterilized.
DNA Dragnet: In Some Cities, Police Go From Stop-and-Frisk to Stop-and-Spitby Lauren KirchnerProPublicaSeptember 12th, 2016Private police DNA databases are multiplying, and are subject to no state or federal regulation or oversight.
Silicon Valley was going to disrupt capitalism. Now it’s just enhancing itby Evgeny MorozovThe GuardianAugust 6th, 2016Tech giants thought they would beat old businesses but the guardians of capitalism are using data troves to become more, not less, resilient.
Stem Cell Therapies Are Still Mostly Theory, Yet Clinics Are Flourishingby Gina KolataThe New York TimesJuly 28th, 2016570 clinics in the United States are offering untested stem cell therapies.
Editas signs genome-edited stem cell pact with GSK, Biogen biotech partnerby Ben AdamsFierce BiotechJuly 28th, 2016Editas Medicine has a hand in a number of gene therapy initiatives.
Congress wrestles with providing fertility benefits for injured veterans and servicemembersby Karoun DemirjianThe Washington PostJuly 27th, 2016Senator Patty Murray believes the ban on IVF and other fertility options is outdated.
Displaying 1-10 of 489  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760